Capvizr

Telepatia Secures $33 Million in Latest Series A Funding Round

Capvizr Staff · · 2 min read

Telepatia secured $33 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Series A$33 millionHealthcare & Life SciencesUndisclosed HQ

Telepatia Raises $33 million in Funding

Telepatia raises $33M Series A led by a16z to build an AI Doctor for Latin American hospitals.

Investors Behind the Funding

The round was backed by Andreessen Horowitz, alongside a16z. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Telepatia operates in Healthcare & Life Sciences. Telepatia's Series A round shows investors are still backing digital health platforms with real scale narratives. At $33M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Build an AI Doctor for Latin American hospitals.

Looking Ahead

Telepatia raises $33M Series A led by a16z to build an AI Doctor for Latin American hospitals

Source reference: original announcement/article.

View Telepatia's full profile and funding history on Capvizr →